Lisata Therapeutics (LSTA) Institutional Ownership → Your $200 account credit is about to expire (From MarketBeat) (Ad) Free LSTA Stock Alerts $3.12 -0.14 (-4.29%) (As of 03/28/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Lisata Therapeutics (NASDAQ:LSTA)CurrentInstitutional OwnershipPercentage8.94%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$134,538.60Number ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$12,151.23 Get LSTA Insider Trade Alerts Want to know when executives and insiders are buying or selling Lisata Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LSTA Institutional Buying and Selling by Quarter Ad MarketBeatYour $200 account credit is about to expireUpdate to MarketBeat All Access and Save $300 on Your Annual SubscriptionStart Your Risk-Free Trial Here Lisata Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/15/2024Citadel Advisors LLC14,131$39K0.0%-24.0%0.174% 1/30/2024 BML Capital Management LLC269,839$0.74M0.6%+10.7%3.315% 8/15/2023Citadel Advisors LLC17,178$64K0.0%N/A0.216% 2/13/2023 BML Capital Management LLC243,839$0.62M0.6%N/A3.102% 2/13/2023Renaissance Technologies LLC92,122$0.23M0.0%-8.7%1.172% 11/15/2022State Street Corp14,349$66K0.0%N/A0.355% 11/15/2022Vanguard Group Inc.176,305$0.82M0.0%N/A4.363% 11/15/2022BlackRock Inc.56,807$0.26M0.0%N/A1.406% 11/14/2022Renaissance Technologies LLC100,922$0.47M0.0%N/A2.497% 11/10/2022Dimensional Fund Advisors LP12,333$57K0.0%N/A0.305% (Data available from 1/1/2016 forward) LSTA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LSTA shares? During the previous two years, the following institutional investors and hedge funds held shares of Lisata Therapeutics shares: Vanguard Group Inc. ($0.82M), BML Capital Management LLC ($0.74M), BlackRock Inc. ($0.26M), Renaissance Technologies LLC ($0.23M), State Street Corp ($66K), and Dimensional Fund Advisors LP ($57K), and Citadel Advisors LLC ($39K).Learn more on LSTA's institutional investors. What percentage of Lisata Therapeutics stock is owned by institutional investors? 8.94% of Lisata Therapeutics stock is owned by institutional investors. Learn more on LSTA's institutional investor holdings. Which institutional investors have been buying Lisata Therapeutics stock? The following institutional investors have purchased Lisata Therapeutics stock in the last 24 months: BML Capital Management LLC ($0.27M), Vanguard Group Inc. ($0.18M), Renaissance Technologies LLC ($0.10M), BlackRock Inc. ($56.81K), Citadel Advisors LLC ($17.18K), State Street Corp ($14.35K), and Dimensional Fund Advisors LP ($12.33K). How much institutional buying is happening at Lisata Therapeutics? Institutional investors have bought a total of 647,733 shares in the last 24 months. This purchase volume represents approximately $2.42M in transactions. Which Lisata Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Lisata Therapeutics stock in the last 24 months: Renaissance Technologies LLC ($8.80K), and Citadel Advisors LLC ($4.45K). How much institutional selling is happening at Lisata Therapeutics? Institutional investors have sold a total of 13,251 shares in the last 24 months. This volume of shares sold represents approximately $34.42K in transactions. Related Companies: Aprea Therapeutics Institutional Ownership Unity Biotechnology Institutional Ownership BioVie Institutional Ownership Cumberland Pharmaceuticals Institutional Ownership MEI Pharma Institutional Ownership Aileron Therapeutics Institutional Ownership TherapeuticsMD Institutional Ownership Sensei Biotherapeutics Institutional Ownership Forte Biosciences Institutional Ownership Orgenesis Institutional Ownership This page (NASDAQ:LSTA) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI healthcare stock poised for 36,996% growth?Behind the MarketsBill Gates is all about this tiny $2 stockTimothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lisata Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.